The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

Starting treatment because of very low number of natural killer cells

Jun 21, 2003

Dr. Young, My CD4 count is OK, but on T cell subsets, I have very, very few natural killer cells and a very low percentage of NKC's. What are the risks and how concerned should I be? Are there ways to boost levels of natural killer cells? Do you recommend starting treatment when there is no detectable viral load, but bad symptoms and VERY few Natural Killer Cells?

I would appreciate your answering this.

Many thanks.

Response from Dr. Young

I am not aware of any literature or clinical opinion on using NK cells as a basis for initiating antiretroviral therapy.

On the other hand, there is quite a bit of literature and opinion that recommends starting antiretroviral therapy for persons with symptomatic HIV infection, irrespective of viral load or CD4 counts. As such, you might be in this situation, if you have "bad" symptoms, and a "normal" CD4 cell count. BY

starting treatment for first time

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint